Physician profile
Phuoc T Tran
NPI 1376739037
$177,225.89
in general payments reported to CMS, 2019-2025
16 companies · $11K in 2025
The $11K reported for 2025 was more than what 97% of Radiation Oncology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,301 · 2020: $20K · 2021: $25K · 2022: $32K · 2023: $44K · 2024: $36K · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $84K · Travel and Lodging: $5,028 · Food and Beverage: $1,970.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $84,295.25 |
| Travel and Lodging | $5,028.19 |
| Food and Beverage | $1,970.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Research & Development, LLC | $94,706.75 | 2020-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $37,922.63 | 2022-2024 | |
| Astellas Pharma US INC | $21,803.24 | 2019-2021 | |
| Pfizer INC. | $8,145.36 | 2019-2023 | |
| Regeneron Pharmaceuticals, INC. | $6,157.56 | 2023 | |
| Astrazeneca Uk Limited | $3,250.00 | 2020 | |
| Novartis Pharmaceuticals Corporation | $2,483.00 | 2024 | |
| Siemens Medical Solutions USA, INC. | $1,745.20 | 2022-2024 | Probeam Proton Therapy System, Varian Ethos Treatment Planning |
| Ethicon INC. | $572.41 | 2023 | Monarch Platform |
| Gt Medical Technologies, INC | $144.39 | 2025 | Gammatile |
| Musculoskeletal Transplant Foundation INC. | $133.82 | 2025 | |
| Reflexion Medical, INC. | $97.49 | 2021 | |
| Myovant Sciences INC. | $27.87 | 2022 | |
| Bioprotect Medical, INC. | $24.94 | 2025 | Bioprotect Balloon Implant System |
| Genentech, INC. | $11.23 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Phuoc Tran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.